What is the share price of Ajanta Pharma Ltd (AJANTPHARM) today?
The share price of AJANTPHARM as on 13th April 2026 is ₹2897.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ajanta Pharma Ltd (AJANTPHARM) share?
The past returns of Ajanta Pharma Ltd (AJANTPHARM) share are- Past 1 week: 3.04%
- Past 1 month: -7.40%
- Past 3 months: 6.10%
- Past 6 months: 19.77%
- Past 1 year: 10.45%
- Past 3 years: 130.88%
- Past 5 years: 151.87%
What are the peers or stocks similar to Ajanta Pharma Ltd (AJANTPHARM)?
The peers or stocks similar to Ajanta Pharma Ltd (AJANTPHARM) include:What is the dividend yield % of Ajanta Pharma Ltd (AJANTPHARM) share?
The current dividend yield of Ajanta Pharma Ltd (AJANTPHARM) is 1.01.What is the market cap of Ajanta Pharma Ltd (AJANTPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ajanta Pharma Ltd (AJANTPHARM) is ₹34942.00 Cr as of 13th April 2026.What is the 52 week high and low of Ajanta Pharma Ltd (AJANTPHARM) share?
The 52-week high of Ajanta Pharma Ltd (AJANTPHARM) is ₹3228 and the 52-week low is ₹2329.90.What is the PE and PB ratio of Ajanta Pharma Ltd (AJANTPHARM) stock?
The P/E (price-to-earnings) ratio of Ajanta Pharma Ltd (AJANTPHARM) is 37.96. The P/B (price-to-book) ratio is 9.22.Which sector does Ajanta Pharma Ltd (AJANTPHARM) belong to?
Ajanta Pharma Ltd (AJANTPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ajanta Pharma Ltd (AJANTPHARM) shares?
You can directly buy Ajanta Pharma Ltd (AJANTPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ajanta Pharma Ltd
AJANTPHARM Share Price
NSE₹2,897.303.25% (+91.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
AJANTPHARM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AJANTPHARM Performance & Key Metrics
AJANTPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.44 | 9.22 | 1.01% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 34.78 | 5.49 | 0.61% |
100%
Analysts have suggested that investors can buy this stock
from 10 analysts
Price Upside
Earnings Growth
Rev. Growth
AJANTPHARM Company Profile
Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.
SUNPHARMA
PE Ratio
38.60
38.60
1Y Return
3.10%
3.10%
Buy Reco %
94.12
94.12
TORNTPHARM
PE Ratio
74.62
74.62
1Y Return
29.77%
29.77%
Buy Reco %
77.78
77.78
LUPIN
PE Ratio
31.99
31.99
1Y Return
15.02%
15.02%
Buy Reco %
72.22
72.22
DRREDDY
PE Ratio
18.45
18.45
1Y Return
7.01%
7.01%
Buy Reco %
51.61
51.61
CIPLA
PE Ratio
18.72
18.72
1Y Return
18.27%
18.27%
Buy Reco %
51.61
51.61
AJANTPHARM Sentiment Analysis
AJANTPHARM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AJANTPHARM Stock Summary · July 2025
Ajanta Pharma demonstrated robust financial performance in Q1 FY 2026, with a 14% revenue increase driven by strong growth in the U.S. Generics segment, despite facing challenges from rising expenses and a foreign exchange loss. The company’s commitment to sustainable growth is evident through increased R&D investments and strategic expansions in emerging markets, particularly in India and Africa, where it outpaced market growth. While operational efficiency remains strong, with an 80% cash conversion ratio, management acknowledges pressures on margins due to rising personnel costs. Looking ahead, Ajanta Pharma is optimistic about achieving mid- to high single-digit growth, supported by new product launches and a focus on enhancing its therapeutic portfolio.
AJANTPHARM Stock Growth Drivers
AJANTPHARM Stock Growth Drivers
6Strong Financial Performance
Ajanta Pharma reported a 14% increase in total revenue for Q1 FY 2026, reaching Rs.
Product Launches and Market Expansion
In Q1 FY 2026, Ajanta Pharma launched 10 new products in the Branded Generic business,
AJANTPHARM Stock Challenges
AJANTPHARM Stock Challenges
6Decline in Africa Antimalarial Business
The Africa Institution's Antimalarial business has seen a decline, contributing only 3% to total revenue
Challenges in Cardiac Division Growth
The cardiac division's growth has been lower than the Indian Pharmaceutical Market (IPM) growth rate,
AJANTPHARM Forecast
AJANTPHARM Forecasts
Price
Revenue
Earnings
AJANTPHARM Share Price Forecast
AJANTPHARM Share Price Forecast
2026
Current
₹2,897.30
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹2,897.30
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
AJANTPHARM Company Revenue Forecast
AJANTPHARM Company Revenue Forecast
2025
Current
₹4.74
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹4.74
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
AJANTPHARM Stock EPS (Earnings Per Share) Forecast
AJANTPHARM Stock EPS (Earnings Per Share) Forecast
2025
Current
₹72.94
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹72.94
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
AJANTPHARM
AJANTPHARM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
AJANTPHARM Income Statement
AJANTPHARM Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,049.77 | 1,118.74 | 1,089.58 | 1,171.39 | 1,206.12 | 1,176.57 | 1,188.52 | 1,328.98 | 1,413.07 | 1,399.81 | ||||||||||
Operating & Other expenses | 737.78 | 791.08 | 775.76 | 814.57 | 875.47 | 825.30 | 873.26 | 951.30 | 1,025.90 | 992.60 | ||||||||||
EBITDA | 311.99 | 327.66 | 313.82 | 356.82 | 330.65 | 351.27 | 315.26 | 377.68 | 387.17 | 407.21 | ||||||||||
| Depreciation/Amortization | 33.71 | 34.26 | 34.25 | 33.97 | 34.39 | 35.97 | 39.78 | 41.29 | 42.97 | 43.51 | ||||||||||
| PBIT | 278.28 | 293.40 | 279.57 | 322.85 | 296.26 | 315.30 | 275.48 | 336.39 | 344.20 | 363.70 | ||||||||||
| Interest & Other Items | 2.34 | 2.49 | 1.53 | 0.73 | 6.02 | 7.91 | 6.07 | 5.26 | 3.39 | 5.10 | ||||||||||
| PBT | 275.94 | 290.91 | 278.04 | 322.12 | 290.24 | 307.39 | 269.41 | 331.13 | 340.81 | 358.60 | ||||||||||
| Taxes & Other Items | 80.64 | 80.88 | 75.32 | 76.35 | 73.76 | 74.51 | 44.15 | 75.79 | 80.62 | 84.83 | ||||||||||
| Net Income | 195.30 | 210.03 | 202.72 | 245.77 | 216.48 | 232.88 | 225.26 | 255.34 | 260.19 | 273.77 | ||||||||||
| EPS | 15.51 | 16.68 | 16.10 | 19.54 | 17.27 | 18.60 | 18.00 | 20.44 | 20.83 | 21.91 |
AJANTPHARM Company Updates
AJANTPHARM Stock Peers
AJANTPHARM Past Performance & Peer Comparison
AJANTPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ajanta Pharma Ltd | 37.96 | 9.22 | 1.01% |
| Sun Pharmaceutical Industries Ltd | 38.60 | 5.82 | 0.91% |
| Torrent Pharmaceuticals Ltd | 74.62 | 18.79 | 0.76% |
| Lupin Ltd | 31.99 | 6.07 | 0.52% |
AJANTPHARM Stock Price Comparison
Compare AJANTPHARM with any stock or ETFCompare AJANTPHARM with any stock or ETF
AJANTPHARM
AJANTPHARM Holdings
AJANTPHARM Shareholdings
AJANTPHARM Promoter Holdings Trend
AJANTPHARM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AJANTPHARM Institutional Holdings Trend
AJANTPHARM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AJANTPHARM Shareholding Pattern
AJANTPHARM Shareholding Pattern
AJANTPHARM Shareholding History
AJANTPHARM Shareholding History
Foreign Institutions
Mutual Funds Invested in AJANTPHARM
Mutual Funds Invested in AJANTPHARM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Ajanta Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3442% | Percentage of the fund’s portfolio invested in the stock 0.76% | Change in the portfolio weight of the stock over the last 3 months 0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 77/263 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0782% | Percentage of the fund’s portfolio invested in the stock 1.84% | Change in the portfolio weight of the stock over the last 3 months 0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/64 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9191% | Percentage of the fund’s portfolio invested in the stock 2.12% | Change in the portfolio weight of the stock over the last 3 months 0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/82 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing AJANTPHARM stock
smallcases containing AJANTPHARM stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Ajanta Pharma Ltd
AJANTPHARM Events
AJANTPHARM Events
AJANTPHARM Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AJANTPHARM has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.01%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.07 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
AJANTPHARM Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AJANTPHARM has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.01%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.07 every year
AJANTPHARM Upcoming Dividends
AJANTPHARM Upcoming Dividends
No upcoming dividends are available
AJANTPHARM Past Dividends
AJANTPHARM Past Dividends
Cash Dividend
Ex DateEx DateNov 10, 2025
Interim 1
Interim 1 | Div/Share: ₹28.00
Dividend/Share
₹28.00
Ex DateEx Date
Nov 10, 2025
Cash Dividend
Ex DateEx DateNov 6, 2024
Interim 1
Interim 1 | Div/Share: ₹28.00
Dividend/Share
₹28.00
Ex DateEx Date
Nov 6, 2024
Cash Dividend
Ex DateEx DateFeb 8, 2024
Interim 2
Interim 2 | Div/Share: ₹26.00
Dividend/Share
₹26.00
Ex DateEx Date
Feb 8, 2024
Cash Dividend
Ex DateEx DateAug 4, 2023
Interim 1
Interim 1 | Div/Share: ₹10.00
Dividend/Share
₹10.00
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateAug 4, 2023
Special
Special | Div/Share: ₹15.00
Dividend/Share
₹15.00
Ex DateEx Date
Aug 4, 2023
AJANTPHARM Stock News & Opinions
AJANTPHARM Stock News & Opinions
Articles & Videos
Spotlight
Ajanta Pharma Ltd spurts 3.48%
Ajanta Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2903.7, up 3.48% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.88% on the day, quoting at 23839.75. The Sensex is at 76813.27, down 0.95%. Ajanta Pharma Ltd has dropped around 1.71% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has dropped around 1.93% in last one month and is currently quoting at 22164.85, down 0.24% on the day. The volume in the stock stood at 74510 shares today, compared to the daily average of 1.05 lakh shares in last one month.The PE of the stock is 37.14 based on TTM earnings ending December 25.
23 hours agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd soars 2.94%, rises for third straight session
Ajanta Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 3137.8, up 2.94% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.61% on the day, quoting at 23722.1. The Sensex is at 76393.47, down 0.61%. Ajanta Pharma Ltd has added around 7.46% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has added around 4.88% in last one month and is currently quoting at 23348.05, down 0.3% on the day. The volume in the stock stood at 1.32 lakh shares today, compared to the daily average of 1.1 lakh shares in last one month.The PE of the stock is 40.35 based on TTM earnings ending December 25.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd soars 0.41%, up for fifth straight session
Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 2974, up 0.41% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.92% on the day, quoting at 25582.55. The Sensex is at 82908.57, down 0.99%. Ajanta Pharma Ltd has risen around 10.8% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has risen around 3.89% in last one month and is currently quoting at 22541.95, up 0.07% on the day. The volume in the stock stood at 32363 shares today, compared to the daily average of 94652 shares in last one month.The PE of the stock is 39.24 based on TTM earnings ending December 25.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ajanta Pharma consolidated net profit rises 17.56% in the December 2025 quarter
Net profit of Ajanta Pharma rose 17.56% to Rs 273.77 crore in the quarter ended December 2025 as against Rs 232.88 crore during the previous quarter ended December 2024. Sales rose 19.95% to Rs 1374.84 crore in the quarter ended December 2025 as against Rs 1146.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1374.841146.13 20 OPM %27.8027.99 - PBDT402.11343.36 17 PBT358.60307.39 17 NP273.77232.88 18 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Ajanta Pharma to table results
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd spurts 0.34%, gains for five straight sessions
Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2948.4, up 0.34% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.6% on the day, quoting at 26303.05. The Sensex is at 85667.85, up 0.56%. Ajanta Pharma Ltd has added around 13.11% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has added around 0.82% in last one month and is currently quoting at 22632.75, up 0.38% on the day. The volume in the stock stood at 1.1 lakh shares today, compared to the daily average of 1.5 lakh shares in last one month.The PE of the stock is 38.6 based on TTM earnings ending September 25.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd gains for third straight session
Ajanta Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2771, up 1.62% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.76% on the day, quoting at 26136.25. The Sensex is at 85259.33, up 0.69%. Ajanta Pharma Ltd has gained around 8.13% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has gained around 0.91% in last one month and is currently quoting at 22540.05, up 0.62% on the day. The volume in the stock stood at 28897 shares today, compared to the daily average of 1.25 lakh shares in last one month.The PE of the stock is 35.82 based on TTM earnings ending September 25.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd soars 0.12%, up for fifth straight session
Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 2609.7, up 0.12% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.09% on the day, quoting at 26009.55. The Sensex is at 85089.75, down 0.02%. Ajanta Pharma Ltd has risen around 1.59% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has risen around 2.76% in last one month and is currently quoting at 22907.85, down 0.19% on the day. The volume in the stock stood at 19677 shares today, compared to the daily average of 72529 shares in last one month.The PE of the stock is 34.25 based on TTM earnings ending September 25.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd rises for third straight session
Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2596, up 1.3% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.48% on the day, quoting at 26049.4. The Sensex is at 85227.88, down 0.48%. Ajanta Pharma Ltd has gained around 2.23% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has gained around 1.98% in last one month and is currently quoting at 22887.75, down 0.01% on the day. The volume in the stock stood at 61812 shares today, compared to the daily average of 89941 shares in last one month.The PE of the stock is 33.66 based on TTM earnings ending September 25.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Ajanta Pharma fixes record date for 1st interim dividend
Ajanta Pharma has fixed 10 November 2025 as record date for payment of first interim dividend. Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.09%, vs industry avg of 9.88%
Over the last 5 years, market share increased from 1.05% to 1.12%
Over the last 5 years, net income has grown at a yearly rate of 14.5%, vs industry avg of 19.69%